1,673 material Form 8-K filings that 1,260 companies we cover made with the SEC in February 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
NW Natural Holdings reported full-year 2025 GAAP EPS of $2.77, up from $2.03, and adjusted EPS of $2.93, up from $2.33. For the fourth quarter, GAAP EPS rose to $1.39 from $1.12, while adjusted EPS was $1.39 versus $1.41 a year earlier. The company set 2026 EPS guidance of $2.95–3.15 and announced the MX3 Mist gas storage expansion, which is expected to cost about $300 million.
Full-year 2025 GAAP net income was $113.3 million ($2.77 per share), up from $78.9 million ($2.03 per share) in 2024.
Fourth-quarter 2025 GAAP net income was $57.8 million ($1.39 per share), up from $45.0 million ($1.12 per share); adjusted EPS was $1.39 versus $1.41.
2026 EPS guidance is $2.95–3.15; the company targets 4.0–6.0% long-term EPS growth through 2030.
MX3 storage expansion is expected to cost about $300 million and be in service by the end of 2029; the company declared a quarterly dividend of $0.4925 per share.
Arlo Technologies reported fourth-quarter and full-year 2025 results on February 26, 2026, with Q4 revenue of $141.3 million, up from $121.6 million a year earlier, and a GAAP profit of $0.05 per share compared with a loss of $0.05. The company also gave first-quarter 2026 revenue guidance of $135 million to $145 million and non-GAAP EPS guidance of $0.17 to $0.23, and said it has a partnership with Comcast for connected home security.
Q4 2025 revenue of $141.3 million, versus $121.6 million in Q4 2024
Q4 2025 GAAP EPS of $0.05 versus a loss of $0.05 in Q4 2024; full-year GAAP EPS of $0.14 versus a loss of $0.31 in 2024
Full-year 2025 revenue of $529.3 million, versus $510.9 million in 2024
Q1 2026 guidance: GAAP revenue of $135 million to $145 million; non-GAAP diluted EPS of $0.17 to $0.23
Concentra reported fourth-quarter 2025 revenue of $539.1 million, up 15.9%, and net income attributable to the Company of $34.7 million, up 61.2%. For full-year 2025, revenue rose 13.9% to $2,163.4 million, while net income attributable to the Company was flat at $166.4 million and EPS fell to $1.30 from $1.46. The company also gave 2026 guidance of $2.25 billion to $2.35 billion in revenue and declared a $0.0625 per share dividend.
Q4 2025 EPS was $0.27 versus $0.17 in Q4 2024; Adjusted EBITDA was $95.3 million, up 22.9%.
Full-year 2025 EPS was $1.30 versus $1.46 in 2024; full-year net income attributable to the Company was $166.4 million, down 0.1%.
2026 guidance: revenue of $2.25 billion to $2.35 billion and Adjusted EBITDA of $450 million to $470 million.
Board declared a $0.0625 per share dividend, payable on or about March 19, 2026, to holders of record on March 12, 2026.
Amphastar reported fourth-quarter and full-year 2025 results on February 26, 2026. Revenue, GAAP net income and diluted EPS declined from 2024 in both periods, and the release does not include financial guidance for 2026. Full-year results include a $23.1 million litigation provision, and glucagon sales fell 45% in the fourth quarter on lower average selling prices and unit volumes.
Q4 2025 net revenues were $183.1 million, down 2% from $186.5 million in Q4 2024
Q4 GAAP diluted EPS was $0.51 vs. $0.74; adjusted non-GAAP diluted EPS was $0.73 vs. $0.92
Full-year 2025 net revenues were $719.9 million vs. $732.0 million; GAAP diluted EPS was $2.03 vs. $3.06
BAQSIMI sales rose 46% to $185.4 million for the full year, while glucagon sales fell 36% to $69.1 million
Monster Beverage reported fourth-quarter and full-year 2025 results on February 26, 2026, with net sales, net income and diluted earnings per share all higher than in 2024. The company also named new regional leaders and said no shares were repurchased in the fourth quarter, leaving about $500.0 million available under its buyback program.
Q4 2025 net income rose 65.9% to $449.2 million, and diluted EPS rose to $0.46 from $0.28 a year earlier.
Full-year 2025 net sales rose 10.7% to $8.29 billion, and diluted EPS rose to $1.94 from $1.49.
Effective February 25, 2026, Rob Gehring became CEO, Americas, Guy Carling became CEO, EMEA & OSP, and Emelie Tirre became Chief Strategy Officer.
No shares were repurchased in Q4 2025; about $500.0 million remained available under the existing repurchase program as of February 26, 2026.
MARA Holdings reported preliminary, unaudited results for the fourth quarter and full year 2025, showing revenue down 6% in the quarter and a net loss of $1.7 billion, compared with net income of $528.3 million a year earlier. The company attributed the swing mainly to a $1.5 billion loss on fair value of digital assets as bitcoin prices fell, and it also announced a joint venture with Starwood Digital Ventures to develop AI and high-performance compute infrastructure. Final figures will come in the Form 10-K, so the reported numbers could change.
Q4 2025 revenue fell 6% to $202.3 million from $214.4 million in Q4 2024, driven by a 14% decrease in the average bitcoin price.
Q4 2025 net loss was $1.7 billion, or $4.52 per diluted share, versus net income of $528.3 million, or $1.24 per diluted share, in Q4 2024.
Full-year 2025 revenue rose 38% to $907.1 million, while the full-year net loss was $1.3 billion compared with net income of $541.0 million in 2024.
Adjusted EBITDA was a loss of $1.5 billion in Q4 2025 versus $796.0 million in Q4 2024; results remain preliminary and unaudited.
MasTec reported fourth quarter 2025 revenue of $3.9 billion, up 16% year over year, and GAAP diluted EPS of $1.81 versus $0.95 a year earlier. The company also issued initial guidance for 2026 of $17.0 billion in revenue and $8.40 in adjusted diluted EPS, compared with $6.55 in 2025, so shareholders get a forecast of continued growth.
Q4 2025 revenue was $3.9 billion, up 15.8% from $3.4 billion; GAAP net income was $153 million versus $85 million
Full-year 2025 revenue was $14.3 billion and GAAP net income was $422 million, both up from 2024
2026 guidance: revenue of $17.0 billion and adjusted EBITDA of $1.45 billion for the full year
Q1 2026 guidance: revenue of $3.475 billion and adjusted diluted EPS of $1.00
Arcosa reported fourth-quarter 2025 net income of $52.1 million, compared with a net loss of $7.7 million a year earlier, and full-year 2025 revenue of $2.88 billion, up 12%. The company also guided to 2026 revenue of $2.95 billion to $3.10 billion and adjusted EBITDA of $590 million to $640 million, excluding its planned $450 million sale of the barge business, which is expected to close in the second quarter of 2026.
Q4 2025 net income was $52.1 million, or $1.06 diluted EPS, versus a net loss of $7.7 million, or $(0.16) per share, in Q4 2024.
Full-year 2025 revenue was $2.88 billion, up 12%, and adjusted EBITDA was $583.3 million, up 30%.
2026 guidance: revenue of $2.95 billion to $3.10 billion and adjusted EBITDA of $590 million to $640 million, excluding the barge divestiture.
Barge business (Arcosa Marine Products) to be sold to Wynnchurch Capital L.P. for $450 million in cash, expected to close in Q2 2026; Group President Jesse E. Collins Jr. retires effective April 3, 2026.
Assured Guaranty reported fourth quarter 2025 net income attributable to the company of $119 million, or $2.53 per diluted share, up from $18 million, or $0.35 per share, a year earlier. For full year 2025, net income was $503 million, or $10.26 per share, compared with $376 million, or $6.87 per share, in 2024. The company also reported that it returned $500 million to shareholders through share repurchases in 2025.
Q4 2025 adjusted operating income was $109 million, or $2.32 per share, versus $66 million, or $1.27 per share, in Q4 2024.
FY 2025 adjusted operating income was $445 million, or $9.08 per share, versus $389 million, or $7.10 per share, in FY 2024.
Q4 2025 gross written premiums were $61 million, down from $186 million in Q4 2024; FY 2025 gross written premiums were $256 million, down from $440 million.
Shareholders' equity attributable to the company was $125.32 per share as of December 31, 2025, up from $108.80 a year earlier.
American Healthcare REIT reported fourth quarter and full year 2025 results on February 26, 2026, showing a swing to net income from prior-year losses and higher Normalized FFO per diluted share. The company also issued 2026 guidance for Normalized FFO of $1.99 to $2.05 per diluted share, with a $2.02 midpoint, compared with $1.72 in 2025. The guidance does not assume any transactions or capital markets activity beyond those already completed.
Q4 2025 GAAP net income attributable to controlling interest was $10.8 million, or $0.06 per diluted share, versus a loss of $31.8 million, or $0.21 per share, in Q4 2024.
Full-year 2025 GAAP net income attributable to controlling interest was $69.8 million, or $0.42 per diluted share, versus a loss of $37.8 million, or $0.29 per share, in 2024.
Normalized FFO was $0.46 per diluted share in Q4 2025 versus $0.40 a year earlier, and $1.72 for 2025 versus $1.41 in 2024; total portfolio same-store NOI grew 11.8% in Q4 and 14.2% for the year.
2026 guidance calls for net income of $0.75 to $0.81 per diluted share and total portfolio same-store NOI growth of 7.0% to 11.0%.
Tutor Perini reported fourth-quarter and full-year 2025 results in a press release furnished as Exhibit 99.1 to a Form 8-K dated February 26, 2026. Full-year revenue rose 28% to $5.5 billion, and the company returned to a profit after a loss in 2024, with diluted EPS of $1.51 compared with a loss of $3.13. The company also gave 2026 adjusted EPS guidance of $4.90 to $5.30, which excludes share-based compensation expense.
2025 revenue was $5.5 billion, up 28% from 2024.
Income from construction operations was $232.0 million in 2025, compared with a loss of $103.8 million in 2024.
Operating cash flow was a record $748.1 million in 2025, up 49% year-over-year.
The company expects 2026 adjusted EPS of $4.90 to $5.30 and does not provide GAAP EPS guidance.
SBA Communications reported fourth-quarter 2025 results, with net income of $370.4 million ($3.47 per diluted share) versus $178.8 million a year earlier, though that figure includes a $226.3 million gain on the sale of its Canadian operations. AFFO per share fell 8.1% to $3.19, and the company issued initial 2026 guidance that excludes all contracted EchoStar revenue while declaring a dividend of $1.25 per share, up about 13%.
Q4 2025 site leasing revenue rose 3.1% to $666.2 million; net income was $370.4 million, or $3.47 per diluted share, versus $1.61 a year earlier.
AFFO fell 9.2% to $340.4 million, and AFFO per share fell 8.1% to $3.19 from $3.47.
2026 outlook projects total revenues of $2,815.0 million to $2,860.0 million and AFFO per share of $11.84 to $12.29, excluding all contracted EchoStar revenue.
Quarterly dividend of $1.25 per share is payable March 27, 2026, to holders of record on March 13, 2026.
DoubleVerify reported fourth-quarter and full-year 2025 results, with full-year revenue up 14% to $748.3 million but net income down to $50.7 million from $56.2 million in 2024. The Board also approved a $300 million share repurchase program that replaces the November 2024 program, and the company guided 2026 revenue growth of 8% to 10%.
Full-year 2025 revenue of $748.3 million, up 14%; net income of $50.7 million versus $56.2 million in 2024, and diluted EPS of $0.30 versus $0.32.
Fourth-quarter 2025 revenue of $205.6 million, up 8%, with net income of $29.3 million.
2026 guidance: full-year revenue of $810 million to $826 million, up 8% to 10%, and adjusted EBITDA margin of about 34%.
Board approved a $300 million repurchase program, replacing the November 2024 program; it has no time limit and does not obligate the company to buy a specific number of shares.
Dentsply Sirona reported a fourth quarter and full-year 2025 net loss, with fourth-quarter net sales up 6.2% but full-year net sales down 3.0%. The company also eliminated its quarterly dividend, announced a restructuring plan, and set 2026 net sales and adjusted EPS outlooks below its 2025 adjusted EPS of $1.60, which matters to shareholders because the dividend is gone and the outlook implies lower per-share earnings.
Q4 2025 net sales were $961 million, up 6.2%, but the company posted a net loss of $146 million, or $0.74 per diluted share, driven by $144 million in net-of-tax goodwill and intangible impairments.
FY 2025 net sales were $3,680 million, down 3.0%, and the net loss was $598 million, or $3.00 per diluted share, compared with a $910 million loss in 2024.
FY 2026 outlook: net sales of $3.5 billion to $3.6 billion and adjusted EPS of $1.40 to $1.50, versus FY 2025 adjusted EPS of $1.60.
The Board eliminated the quarterly cash dividend, which the company said will redirect capital to debt retirement and share repurchases; a restructuring plan carries $55 million to $65 million in charges and about $120 million in annualized
National Health Investors reported fourth quarter 2025 results and introduced 2026 annual guidance. Diluted earnings per share fell to $0.80 from $0.95 a year earlier, while normalized FFO per diluted share rose to $1.22 from $1.12, and the company projects 2026 normalized FFO per diluted share of $4.94 to $4.99.
Q4 2025 diluted EPS was $0.80 versus $0.95 in Q4 2024; NAREIT FFO per diluted share was $1.22 versus $1.24.
Full-year 2025 normalized FFO per diluted share was $4.91 versus $4.44 in 2024; diluted EPS was $3.02 versus $3.13.
2026 guidance: normalized FFO per diluted share of $4.94 to $4.99 and normalized FAD of $248.9 million to $251.4 million.
As of December 31, 2025, net debt was $1.2 billion and net debt to adjusted EBITDA was 3.8x.
Rocket Lab reported fourth-quarter 2025 revenue of $179.7 million, up from $132.4 million a year earlier, and full-year revenue of $601.8 million, up from $436.2 million. The company also guided to first-quarter 2026 revenue of $185 million to $200 million, but its net loss widened for the full year to $198.2 million from $190.2 million.
Q4 2025 revenue $179.7 million vs $132.4 million in Q4 2024; net loss $52.9 million, or $0.09 per share, vs $52.3 million, or $0.10 per share
Full-year 2025 revenue $601.8 million vs $436.2 million in 2024; net loss $198.2 million, or $0.37 per share
Q1 2026 guidance: revenue $185 million to $200 million; adjusted EBITDA loss $21 million to $27 million
Backlog reached $1.85 billion at year-end, up 73% year on year; Neutron first launch now targeted for Q4 2026
Dell reported record fiscal 2026 fourth-quarter revenue of $33.4 billion, up 39%, and record full-year revenue of $113.5 billion, up 19%. It guided fiscal 2027 revenue to $138.0 billion to $142.0 billion, and it raised its cash dividend by 20% and its share repurchase authorization by $10 billion.
Q4 FY26 revenue of $33.4 billion, up 39%; diluted EPS of $3.37, up 57%
FY26 revenue of $113.5 billion, up 19%; diluted EPS of $8.68, up 36%
FY27 revenue guidance of $138.0 billion to $142.0 billion; GAAP diluted EPS midpoint of $11.52
Strategic Education reported fourth quarter 2025 revenue of $323.2 million, up 3.8%, and diluted earnings per share of $1.66 compared with $1.05 a year earlier. For full-year 2025, revenue rose 4.0% to $1,268.2 million and diluted EPS was $5.41 versus $4.67, with the company also declaring a $0.60 quarterly dividend for shareholders of record as of March 9, 2026.
Q4 2025 income from operations was $51.6 million, or 16.0% of revenue, versus $36.0 million, or 11.6%, in Q4 2024
Full-year 2025 net income was $126.6 million, compared with $112.7 million in 2024, and the company repurchased shares for $138.9 million during the year
Quarterly cash dividend of $0.60 per share, payable March 16, 2026
The filing does not include financial guidance for 2026
Brink's reported fourth-quarter 2025 revenue of $1,379 million, up 9% (5% organic), and GAAP earnings per share of $1.62, up 93%. For full-year 2025, revenue reached $5,261 million (up 5%) and GAAP EPS was $4.70 (up 30%), and the company gave first-quarter 2026 non-GAAP guidance and a 2026 framework.
Q4 2025 operating profit was $180 million on a GAAP basis, up 72%, and non-GAAP EPS was $2.54, up 20%.
Full-year 2025 adjusted EBITDA was $977 million, up 7%, with operating cash flow of $640 million and free cash flow of $436 million.
Q1 2026 non-GAAP guidance calls for revenue of $1,335 million to $1,395 million, adjusted EBITDA of $220 million to $240 million, and EPS of $1.50 to $1.90.
Net debt leverage fell to 2.7 times adjusted EBITDA, and the company returned over $250 million to shareholders through dividends and share repurchases.
Fox Factory reported fourth-quarter fiscal 2025 net sales of $361.1 million, up 2.3%, but posted a net loss of $287.0 million, or $6.86 per diluted share, driven mainly by goodwill impairment. Adjusted EBITDA fell to $35.0 million from $40.4 million, and the company launched a Phase 2 profit plan and introduced fiscal 2026 guidance for adjusted EBITDA of $174 million to $203 million.
Q4 net sales rose 2.3% to $361.1 million; net loss was $287.0 million, or $6.86 per diluted share, versus a $0.1 million loss a year earlier.
Adjusted EPS was $0.20 versus $0.31 in the prior-year quarter; adjusted EBITDA was $35.0 million versus $40.4 million.
Full-year fiscal 2025 goodwill impairment was $557.3 million; goodwill fell to $83.6 million from $639.5 million.
Phase 2 targets about $40 million in additional savings in 2026; fiscal 2026 net sales guidance is $1.328 billion to $1.416 billion, and the company expects to divest its Phoenix, Arizona AAG operations by the end of Q1 fiscal 2026.
Solventum reported fourth-quarter 2025 net sales of $1,998 million, down 3.7% on a reported basis but up 3.5% organically, and introduced 2026 full-year guidance. Adjusted diluted EPS rose to $1.57 from $1.41, while the company guided to 2026 adjusted EPS of $6.40 to $6.60, compared with $6.11 for full-year 2025.
Q4 2025 reported net sales of $1,998 million, down 3.7%; organic sales up 3.5%
Q4 2025 GAAP diluted EPS of $0.36 versus $0.17; adjusted diluted EPS of $1.57 versus $1.41
2026 guidance: organic sales growth of 2.0% to 3.0%, adjusted EPS of $6.40 to $6.60, and free cash flow of about $200 million
Full-year 2025 free cash flow was negative $10 million and adjusted EPS was $6.11, down 8.8%
Sunrun reported fourth-quarter 2025 revenue of $1,158.8 million, up 124% from a year earlier, and net income attributable to common stockholders of $103.6 million, compared with a loss of $2.81 billion a year earlier that included a $3.1 billion goodwill impairment. However, the company's Contracted Net Value Creation fell 44% to $176 million, and it gave full-year 2026 guidance for Contracted Net Value Creation of $650 million to $1.05 billion and Cash Generation of $250 million to $450 million.
Q4 2025 total revenue was $1,158.8 million, up $640.3 million, or 124%, driven partly by a third-quarter 2025 transaction in which certain systems were sold to a third party.
Q4 2025 net income attributable to common stockholders was $103.6 million ($0.38 per diluted share), versus a loss of $2,813.7 million in Q4 2024.
Contracted Net Value Creation was $176 million in Q4 2025, down 44%, and Subscriber Additions were 25,475, down 17%.
For full-year 2026, Sunrun expects Aggregate Subscriber Value of $4.8 billion to $5.2 billion and Contracted Net Value Creation of $650 million to $1.05 billion.
BioLife Solutions reported fourth quarter and full year 2025 results and introduced 2026 guidance of $112.5 million to $115.0 million in revenue, up 17% to 20%. Revenue grew in both periods and the company returned to a quarterly net profit from continuing operations, but the full-year loss from continuing operations widened to $12.1 million from $8.8 million, including a $15.5 million in-process R&D expense.
Q4 2025 revenue from continuing operations was $24.8 million, up 20% from $20.7 million; full-year revenue was $96.2 million, up 29%.
Q4 2025 GAAP net income from continuing operations was $2.1 million, or $0.04 per share, compared with a $1.2 million loss in Q4 2024.
Full-year 2025 GAAP net loss from continuing operations was $12.1 million, compared with $8.8 million in 2024; adjusted EBITDA was $25.0 million, or 26% of revenue.
The company completed the sale of evo on October 6, 2025, for $25.5 million in cash; cash, equivalents and marketable securities were $120.2 million at December 31, 2025.
Talen Energy reported a full-year 2025 GAAP net loss attributable to stockholders of $219 million, compared with net income of $998 million in 2024. The loss reflects a $501 million fourth-quarter charge tied to a change in accounting for certain stock-based awards, while Adjusted EBITDA rose to $1,035 million from $770 million and Adjusted Free Cash Flow reached $524 million. The company reaffirmed its 2026 guidance of $1,750 million to $2,050 million in Adjusted EBITDA, which excludes the pending Cornerstone Acquisition.
Full-year 2025 GAAP net loss attributable to stockholders was $219 million, versus net income of $998 million in 2024.
Full-year 2025 Adjusted EBITDA was $1,035 million, up from $770 million, and Adjusted Free Cash Flow was $524 million, up from $283 million.
The company reaffirmed 2026 Adjusted EBITDA guidance of $1,750 million to $2,050 million and Adjusted Free Cash Flow guidance of $980 million to $1,180 million.
Talen signed a definitive agreement on January 15, 2026 for the Cornerstone Acquisition, with a purchase price of $3.45 billion, expected to close early in the second half of 2026.
DiamondRock Hospitality reported fourth quarter and full year 2025 results. Q4 net income attributable to common stockholders was $23.8 million, or $0.12 per diluted share, compared with a loss of $13.7 million a year earlier, and Adjusted FFO per diluted share rose 12.5% to $0.27. The company also issued 2026 guidance of $287 million to $302 million in Adjusted EBITDA and $1.09 to $1.16 in Adjusted FFO per share, against 2025 Adjusted EBITDA of $297.6 million.
Q4 2025 Adjusted EBITDA was $71.9 million, up 3.3%, and comparable RevPAR fell 0.3% to $201.83
Full year 2025 Adjusted FFO per diluted share was $1.08, up 3.8%, and full year net income attributable to common stockholders was $91.6 million, or $0.44 per diluted share
2026 guidance: Adjusted EBITDA $287 million to $302 million and Adjusted FFO per share $1.09 to $1.16, versus 2025 actuals of $297.6 million and $1.08
Preferred stock redeemed December 31, 2025 for $121.5 million; regular quarterly dividend of $0.09 per share payable April 14, 2026
Evertec reported preliminary fourth-quarter 2025 results, with revenue up 13.1% but GAAP net income attributable to common shareholders down 11.2%, driven by higher depreciation, amortization, cost of revenues and personnel expenses. Full-year 2025 revenue rose 10.2% and GAAP net income rose 25.7%, and the board raised the share repurchase authorization to $150 million through December 31, 2027, with about $84.4 million remaining before the increase.
Q4 2025 revenue was $244.8 million, up 13.1% from $216.4 million; GAAP net income attributable to common shareholders was $35.6 million, or $0.56 per diluted share, down 11.2%.
Full-year 2025 revenue was $931.8 million, up 10.2%; GAAP net income was $141.6 million, or $2.20 per diluted share, up 25.7%.
On February 25, 2026, the board approved raising the share repurchase authorization to $150 million through December 31, 2027.
The revised 2026 outlook calls for total revenue of $1,024 million to $1,036 million and adjusted earnings per share of $3.84 to $3.96.
Autodesk reported fourth-quarter fiscal 2026 revenue of $1.96 billion, up 19% from a year earlier, and GAAP diluted earnings of $1.48 per share, up from $1.40. The company also issued fiscal 2027 guidance for revenue of $8.100 billion to $8.170 billion and GAAP diluted EPS of $7.76 to $8.39, and said it expects temporary risk to billings and revenue as it rolls out a sales optimization plan.
Q4 fiscal 2026 revenue was $1,957 million, up 19%, and non-GAAP diluted EPS was $2.85, up from $2.29
Restructuring, other exit costs, and facility reductions were $100 million in Q4, up from $15 million a year earlier
Fiscal 2027 guidance: revenue $8,100 million to $8,170 million, free cash flow $2,700 million to $2,800 million
First-quarter fiscal 2027 revenue guidance is $1,885 million to $1,900 million
CoreWeave reported fourth-quarter and full-year 2025 results, with revenue up sharply from a year earlier. The net loss also widened substantially, and the company reported a revenue backlog of $66.8 billion as of December 31, 2025. The company said it will give forward-looking guidance on its earnings call, so shareholders will not see guidance in this filing.
Q4 2025 revenue was $1,572 million, compared with $747 million in Q4 2024.
Q4 2025 net loss was $452 million, or $0.89 per share, compared with a net loss of $51 million, or $0.34 per share, a year earlier.
Full-year 2025 revenue was $5,131 million, compared with $1,915 million in 2024, and full-year net loss was $1,167 million.
Revenue backlog was $66.8 billion as of December 31, 2025; the company will provide guidance on its earnings call.
NetApp reported third-quarter fiscal 2026 results for the quarter ended January 23, 2026, with net revenues of $1.71 billion, up 4% year over year, and GAAP diluted earnings per share of $1.67, up from $1.44. The company also guided fourth-quarter net revenues to $1.795 billion to $1.945 billion and full-year fiscal 2026 GAAP EPS to $6.07 to $6.17, which matters to shareholders because it sets the company's near-term financial expectations.
Net revenues were $1.71 billion, up 4% from $1.64 billion; billings were $1.89 billion, up 10%.
GAAP diluted EPS was $1.67 versus $1.44 a year earlier; non-GAAP diluted EPS was $2.12 versus $1.91.
Fourth-quarter fiscal 2026 net revenue guidance is $1.795 billion to $1.945 billion, with GAAP EPS of $1.76 to $1.86.
Cash provided by operations was $317 million, down 18% from $385 million; the company returned $303 million to stockholders.
Progyny reported fourth-quarter 2025 revenue of $318.4 million, up 6.7%, and full-year revenue of $1,288.7 million, up 10%. Full-year diluted earnings per share rose to $0.65 from $0.57, and the company issued 2026 guidance for revenue of $1.355 billion to $1.405 billion and net income of $95.4 million to $106.1 million. The Q1 2026 revenue outlook of (1.6)% to 2.5% growth signals modest near-term growth.
Q4 2025 revenue was $318.4 million, up from $298.4 million; a large client that did not renew contributed $35.9 million in Q4 2024 and none in Q4 2025.
Full-year 2025 net income was $58.5 million, or $0.65 per diluted share, versus $54.3 million, or $0.57, in 2024.
2026 outlook: revenue of $1.355 billion to $1.405 billion and net income of $95.4 million to $106.1 million.
Q1 2026 revenue is projected at $319.0 million to $332.0 million, growth of (1.6)% to 2.5%.
MP Materials reported fourth-quarter 2025 net income of $9.4 million, compared with a net loss of $22.3 million a year earlier, while revenue fell 14% to $52.7 million. The quarter was lifted by $51.0 million of price protection agreement income tied to the U.S. Department of War's NdPr price floor, which began October 1, 2025, and by the company's cessation of rare earth concentrate sales to China. For full year 2025, revenue rose 10% to $224.4 million, but the net loss widened to $85.9 million from $65.4 million.
Q4 2025 revenue of $52.7 million, down 14% year over year; diluted EPS of $0.05 versus $(0.14) in Q4 2024
Q4 2025 Adjusted EBITDA of $39.2 million versus $(10.7) million a year earlier, including $51.0 million of price protection agreement income
Full year 2025 revenue of $224.4 million, up 10%; net loss of $85.9 million; diluted EPS of $(0.50) versus $(0.57) in 2024
The filing contains no forward revenue or earnings guidance; the release says the company expects to break ground on its Northlake, Texas 10X magnetics facility in 2026
Intuit reported fiscal second-quarter 2026 results for the quarter ended January 31, 2026, with revenue of $4.7 billion, up 17%, and GAAP diluted earnings per share of $2.48, up 49%. The company reiterated its full-year fiscal 2026 guidance, issued third-quarter guidance, and declared a $1.20 per share quarterly dividend, which the filing says is a 15% increase from the same period last year.
Q2 revenue was $4.7 billion, up 17%; Global Business Solutions revenue rose 18% to $3.2 billion and Consumer revenue rose 15% to $1.5 billion.
GAAP diluted EPS was $2.48, up 49%; non-GAAP diluted EPS was $4.15, up 25%.
Full-year fiscal 2026 guidance was reiterated: revenue of $20.997 billion to $21.186 billion and non-GAAP diluted EPS of $22.98 to $23.18.
Third-quarter fiscal 2026 non-GAAP diluted EPS is expected at $12.45 to $12.51; the $1.20 dividend is payable April 17, 2026 to holders of record on April 9, 2026.
Pacira reported fourth-quarter 2025 revenue of $196.9 million, up 5 percent, and GAAP net income of $1.6 million, or $0.04 per diluted share, down from $16.0 million, or $0.34 per diluted share, a year earlier. For full-year 2025, revenue rose 4 percent to $726.4 million and GAAP net income was $7.0 million, compared with a net loss of $99.6 million in 2024. The company also issued 2026 guidance for total revenue of $745 million to $770 million.
Q4 2025 total revenue was $196.9 million, up 5 percent from $187.3 million; EXPAREL net product sales were $155.8 million, up 5 percent.
Q4 2025 total operating expenses were $194.5 million versus $162.5 million; SG&A was $101.6 million versus $79.6 million, which the company said included unanticipated business development due diligence and litigation costs.
Q4 2025 non-GAAP net income was $24.4 million, or $0.57 per diluted share, compared with $44.3 million, or $0.91 per diluted share, in Q4 2024.
2026 guidance: EXPAREL net product sales of $600 million to $620 million and total revenue of $745 million to $770 million.
Alignment Healthcare reported fourth-quarter 2025 total revenue of $1,012.8 million, up 44.4%, and a net loss of $11.0 million, compared with a $31.1 million loss a year earlier. For full-year 2025, revenue was $3.95 billion, up 46.1%, and the net loss narrowed to $1.0 million from $128.1 million. The company guided 2026 revenue to $5.14 billion to $5.19 billion and adjusted EBITDA to $133 million to $163 million, which signals expected continued growth and a path toward profitability for shareholders.
Q4 2025 total revenue was $1,012.8 million, up 44.4%; net loss was $11.0 million versus $31.1 million a year earlier.
Full-year 2025 revenue was $3.95 billion, up 46.1%; net loss was $1.0 million versus $128.1 million in 2024.
2026 guidance: revenue of $5.14 billion to $5.19 billion, adjusted EBITDA of $133 million to $163 million, and 292,000 to 298,000 health plan members.
Health plan membership guidance was raised by 2,000 at the midpoint; membership at the end of Q4 2025 was about 236,300, up 25.0%.
DXP Enterprises reported fourth-quarter and fiscal 2025 results on February 25, 2026. Sales and net income rose in both periods, with Q4 diluted EPS up to $1.39 from $1.29 and full-year diluted EPS up to $5.37 from $4.22. The filing gives no forward guidance, and the company said it raised an incremental $205 million under its Term Loan B during the fourth quarter.
Q4 2025 sales rose 12.0% to $527.4 million; Q4 net income rose 6.9% to $22.8 million
Q4 diluted EPS was $1.39 vs. $1.29 a year earlier; adjusted diluted EPS was $1.39 vs. $1.38
Fiscal 2025 sales rose 11.9% to $2.0 billion; net income rose 25.8% to $88.7 million
Refinancing raised an incremental $205 million and cut borrowing costs by 50 basis points; cash was $303.8 million at year end
International Bancshares Corporation (IBC) reported annual net income of approximately $412.3 million, or $6.62 per diluted share, for the year ended December 31, 2025, up about 0.8% from 2024. Net income for the three months ended December 31, 2025 fell about 7.1% year over year to approximately $106.9 million, and fourth-quarter diluted EPS fell 7.6% to $1.71. Shareholders see a slight full-year gain alongside a weaker fourth quarter, with the company citing higher interest expense from rates paid on deposits.
Full-year 2025 net income of approximately $412.3 million, or $6.62 diluted EPS, versus $409.2 million, or $6.57, in 2024
Fourth-quarter 2025 net income of approximately $106.9 million, or $1.71 diluted EPS, versus $115.1 million, or $1.85, in the same period of 2024
Net interest income was negatively affected by higher interest expense, primarily from increased rates paid on deposits
Total assets were approximately $16.6 billion at December 31, 2025, compared with $15.7 billion a year earlier
Sempra reported full-year 2025 GAAP earnings of $1.80 billion, or $2.75 per diluted share, down from $2.82 billion, or $4.42, in 2024, mainly due to large regulatory disallowances and tax items. On an adjusted basis, full-year earnings rose to $3.07 billion, or $4.69 per share, from $4.65, while fourth-quarter adjusted EPS fell to $1.28 from $1.50. The company affirmed its 2026 adjusted EPS guidance of $4.80 to $5.30, issued 2027 guidance of $5.10 to $5.70, and raised its five-year capital plan to $65 billion.
Full-year 2025 GAAP EPS was $2.75, versus $4.42 in 2024; fourth-quarter GAAP EPS was $0.54, versus $1.04.
Full-year 2025 adjusted EPS was $4.69, versus $4.65 in 2024; fourth-quarter adjusted EPS was $1.28, versus $1.50.
Five-year 2026-2030 capital plan raised to approximately $65 billion from $56 billion; 2026 adjusted EPS guidance of $4.80 to $5.30 affirmed.
Quarterly dividend declared at $0.6575 per share, payable April 15, 2026, an annualized $2.63 versus $2.58 in 2025.
Essential Utilities reported full-year 2025 net income of $616.4 million, or $2.20 per share, up from $2.17 in 2024, on revenues of $2.47 billion, up 18.6%. Fourth-quarter net income fell to $132.7 million, or $0.47 per share, from $184.8 million, or $0.67, a year earlier. Shareholders of both companies approved the proposed merger with American Water on February 10, 2026, and the merger remains on track to close in the first quarter of 2027.
Full-year 2025 revenues rose 18.6% to $2,474.6 million from $2,086.1 million, and EPS was $2.20 versus $2.17 in 2024.
Fourth-quarter 2025 net income was $132.7 million, or $0.47 per share, down from $184.8 million, or $0.67, in the fourth quarter of 2024.
Latest guidance targets long-term EPS growth of 5% to 7% compounded annually through 2027, from an adjusted 2024 base of $1.97, with $1.7 billion of regulated infrastructure investment expected in 2026.
The board declared a quarterly dividend of $0.3426 per share, payable June 1, 2026.
Standard Motor Products reported fourth-quarter and full-year 2025 results on February 26, 2026, with net sales up 12.2% in the quarter and 22.4% for the year, and it raised its quarterly dividend. Full-year GAAP diluted EPS from continuing operations rose to $3.52 from $2.41, and the company guided to low to mid-single digit sales growth and an adjusted EBITDA margin of 11%-12% for 2026.
Q4 net sales were $385.1 million, up from $343.4 million; GAAP diluted EPS from continuing operations was $0.41 versus a $0.04 loss a year earlier.
Full-year 2025 net sales were $1.79 billion; adjusted diluted EPS was $4.02, up 26.8% from $3.17.
2026 guidance: low to mid-single digit sales growth and adjusted EBITDA margin of 11.0%-12.0%.
Quarterly dividend increased from $0.31 to $0.33 per share, payable March 2, 2026.
EMCOR reported record fourth-quarter and full-year 2025 revenue and diluted EPS, and gave 2026 guidance of $17.75 billion to $18.50 billion in revenue and $27.25 to $29.25 in diluted EPS. Fourth-quarter GAAP diluted EPS included a $144.9 million gain on the sale of its United Kingdom operations, and non-GAAP diluted EPS was $7.19. Remaining performance obligations reached a record $13.25 billion, which the company cites as support for its 2026 outlook.
Q4 2025 revenues were $4.51 billion, up 19.7% from $3.77 billion; organic growth was 9.5%.
Q4 2025 GAAP diluted EPS was $9.68 versus $6.32 a year earlier; non-GAAP diluted EPS was $7.19.
Full-year 2025 revenues were $16.99 billion and GAAP diluted EPS was $28.19; non-GAAP diluted EPS was $25.87.
2026 guidance: revenues of $17.75 billion to $18.50 billion, operating margin of 9.0% to 9.4%, and diluted EPS of $27.25 to $29.25.
Millrose Properties reported fourth-quarter 2025 net income of $122.2 million, or $0.74 per share, and AFFO of $0.76 per share, with full-year 2025 net income of $379.9 million, or $2.44 per share. The company expects to deploy about $1 billion of additional invested capital by mid-2026, with up to $2 billion of total net new capital deployment for full-year 2026, which it says implies about 10% year-over-year AFFO per share growth.
Q4 2025 net income attributable to common shareholders was $122.2 million, or $0.74 per share; Q4 AFFO was $125.6 million, or $0.76 per share.
Full-year 2025 net income was $379.9 million, or $2.44 per share; full-year AFFO was $427.9 million, or $2.58 per share.
2026 outlook targets a second-quarter 2026 exit AFFO run rate of $0.78 to $0.80 per share and up to $2 billion of net new capital deployment for the full year.
Invested Capital outside the Lennar Master Program Agreement reached about $2.4 billion, above the $2.2 billion stretch target; the filing reports zero option terminations.
PSEG reported full-year 2025 net income of $2.11 billion, or $4.22 per share, up from $3.54 per share in 2024, and non-GAAP operating earnings of $4.05 per share, up from $3.68. It initiated 2026 non-GAAP operating earnings guidance of $4.28 to $4.40 per share, about 7% above 2025 at the midpoint, and raised its indicative 2026 dividend to $2.68 per share, but fourth-quarter operating earnings fell to $0.72 per share from $0.84.
Full-year 2025 non-GAAP operating earnings were $2.03 billion, or $4.05 per share, versus $1.84 billion, or $3.68 per share, in 2024.
Fourth-quarter 2025 non-GAAP operating earnings were $362 million, or $0.72 per share, down from $421 million, or $0.84 per share, a year earlier.
The 2026 non-GAAP operating earnings guidance range is $4.28 to $4.40 per share.
The regulated 2026-2030 capital spending plan is $22.5 billion to $25.5 billion, and the 2026 indicative annual dividend is $2.68 per share, up $0.16.
Koppers reported fourth-quarter 2025 net sales of $432.7 million, down 9.3% from a year earlier, while net income attributable to Koppers rose to $29.7 million from a loss of $10.2 million. Adjusted EPS fell to $0.70 from $0.77 in the quarter and to $4.07 from $4.11 for the full year. The company forecast 2026 adjusted EPS of $4.20 to $5.00 and net sales of $1.9 billion to $2.0 billion.
Q4 2025 diluted EPS was $1.47 versus a loss of $(0.50) per share in Q4 2024.
Full-year 2025 net sales were $1.88 billion versus $2.09 billion in 2024; full-year diluted EPS was $2.74 versus $2.46.
2026 outlook calls for adjusted EBITDA of $250 million to $270 million, compared with $257 million in 2025.
In February 2026 the company decided to idle production at its Vance, Alabama and Florence, South Carolina facilities.
Universal Health Services reported fourth-quarter 2025 net income attributable to UHS of $445.9 million, or $7.06 per diluted share, up from $332.4 million, or $4.96, a year earlier, on net revenues up 9.1% to $4.486 billion. It also issued a 2026 forecast of $18.417 billion to $18.789 billion in net revenues and $22.64 to $24.52 in diluted EPS, and disclosed that a Nevada judge granted a new trial in a lawsuit where a jury had awarded $500 million in punitive damages against a subsidiary, which the company says would likely be vacated.
Q4 2025 net income attributable to UHS was $445.9 million ($7.06 per diluted share) vs. $332.4 million ($4.96) in Q4 2024; adjusted EPS was $5.88 vs. $4.92.
Q4 2025 net revenues rose 9.1% to $4.486 billion; full-year 2025 net revenues were $17.365 billion.
2026 forecast: net revenues of $18.417 billion to $18.789 billion and diluted EPS of $22.64 to $24.52.
On February 25, 2026, the judge in the Washoe County, Nevada case granted a new trial over juror misconduct; the company had recorded an $18 million legal reserve in Q3 2025.
Vericel reported fourth-quarter 2025 total revenue of $92.9 million, up 23%, and net income of $23.2 million, up 17%. For the full year, revenue rose 16% to $276.3 million and net income rose 59% to $16.5 million. The company guided 2026 total revenue to $316 million to $326 million and MACI revenue to $280 million to $286 million.
Q4 2025 net income was $23.2 million, or $0.45 per diluted share, versus $19.8 million, or $0.38, in Q4 2024
Full-year 2025 net income was $16.5 million, or $0.32 per diluted share, versus $10.4 million, or $0.20, in 2024
2026 guidance: total revenue of $316 to $326 million, gross margin of about 75%, and adjusted EBITDA margin of about 27%
Operating expenses rose to $50.7 million in Q4 2025 from $40.0 million, mainly from headcount and costs tied to the new Burlington facility
ACI Worldwide reported full-year 2025 revenue of $1.76 billion, up 10%, and net income of $227 million, up 12%. It guided 2026 revenue to $1.88 billion to $1.91 billion, or 7% to 9% growth, and adjusted EBITDA to $530 million to $550 million. Fourth-quarter net income fell to $64.3 million from $98.6 million, and two directors resigned while Kimberly deBeers joined the board.
Full-year 2025 revenue was $1.76 billion, up 10%; net income was $227 million, up 12%; diluted EPS was $2.16 versus $1.91.
Fourth-quarter 2025 net income was $64.3 million versus $98.6 million a year earlier; diluted EPS was $0.62 versus $0.93.
2026 guidance: revenue of $1.88 billion to $1.91 billion and adjusted EBITDA of $530 million to $550 million, compared with $506 million in 2025.
Charles Peters and Janet Estep resigned from the board effective February 23, 2026; Kimberly deBeers was appointed as an independent director the same day.
ACM Research reported fourth quarter 2025 revenue of $244.4 million, up 9.4%, but GAAP net income attributable to the company fell to $8.0 million from $31.1 million, and diluted EPS dropped to $0.11 from $0.46. For the full year, revenue rose 15.2% to $901.3 million while net income fell to $94.1 million from $103.6 million, and the company kept its 2026 revenue guidance of $1.08 billion to $1.175 billion.
Q4 2025 revenue was $244.4 million, up 9.4%, while Q4 GAAP gross margin fell to 40.9% from 49.6%.
Full-year 2025 GAAP diluted EPS was $1.37, down from $1.53 in 2024.
The company maintained its fiscal 2026 revenue guidance range of $1,080 million to $1,175 million.
Net cash was $845.5 million at December 31, 2025, versus $259.1 million a year earlier.
Gibraltar Industries reported fourth-quarter 2025 net sales of $268.7 million, up 16.0%, while adjusted diluted EPS fell 14.6% to $0.76 and adjusted EBITDA fell 7.6% to $36.6 million. The company also issued 2026 guidance that includes OmniMax International, which closed on February 2, 2026, with adjusted EPS expected between $3.65 and $4.05 versus $3.92 in 2025.
Q4 2025 net sales $268.7 million (up 16.0%); GAAP income from continuing operations $11.8 million (down 75.1%)
Full-year 2025 net sales $1.14 billion (up 11.0%); GAAP diluted EPS $3.25 versus $4.39 in 2024
2026 guidance: net sales $1.76 billion to $1.83 billion; adjusted EPS $3.65 to $4.05 versus $3.92 in 2025
Full-year 2025 net loss of $44.4 million, including a $141.9 million loss from discontinued operations
Lantheus reported fourth-quarter 2025 revenue of $406.8 million, up 4.0%, and GAAP diluted EPS of $0.82 versus a loss of $(0.17) a year earlier. For full year 2025, revenue was $1.54 billion, up 0.5%, while adjusted diluted EPS fell to $6.08 from $6.76. The company also said it is pursuing value-maximizing alternatives for its radiotherapeutic assets and issued 2026 revenue guidance of $1.4 billion to $1.45 billion and adjusted diluted EPS guidance of $5.00 to $5.25.
Q4 2025 revenue $406.8 million, up 4.0%; Q4 adjusted operating income down 8.5% to $138.9 million
Full year 2025 GAAP diluted EPS $3.41 versus $4.36 in 2024; adjusted diluted EPS $6.08 versus $6.76
Company repurchased $100 million of common stock in Q4 2025 and completed the divestiture of the legacy SPECT business to SHINE Technologies effective January 1, 2026
FY 2026 guidance: revenue $1.4 billion to $1.45 billion; adjusted diluted EPS $5.00 to $5.25
Installed Building Products reported fourth-quarter 2025 net income of $76.6 million, up 14.5% and a record, with diluted EPS of $2.83, up 18.4%. Net revenue fell 0.4% to $747.5 million, while full-year net revenue rose 1.0% to a record $3.0 billion and full-year diluted EPS rose to $9.71 from $9.10. The board also approved a $0.39 quarterly dividend and a $1.80 annual variable dividend, both payable March 31, 2026, and a new $500 million buyback program.
Q4 net income $76.6 million, up from $66.9 million; diluted EPS $2.83 versus $2.39 a year earlier
Q4 net revenue $747.5 million, down 0.4%; residential same branch sales fell 9.3% while commercial rose 22.9%
Dividends: $0.39 quarterly and $1.80 annual variable, payable March 31, 2026 to holders of record March 13, 2026
New $500 million buyback replaces the prior program and runs through March 1, 2027
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.